Verastem to Present New COPIKTRA Dose Modification Data from Patients Treated in the Phase 3 DUO Study May 15, 2019
Verastem Announces Publication of Phase 2 Study Results in Indolent Non-Hodgkin Lymphoma in the Journal of Clinical Oncology February 14, 2019
Verastem Oncology Outlines Strategic Priorities for 2019 and Highlights Recent Progress January 3, 2019
